Trump eyes 'important' announcement on Autism

21/9/2025 11:16

U.S. President Donald Trump said on Saturday his administration would make an announcement about its autism findings on Monday (US Time), declining to offer specifics.



The Wall Street Journal reported this month that Health Secretary Robert F. Kennedy Jr. plans to announce that use of Kenvue's popular over-the-counter pain medication Tylenol by pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use.



Autism diagnoses in the United States have increased significantly since 2000, intensifying public concern.



By 2020, the U.S. autism rate in 8-year-olds was 1 in 36, or 2.77%, up from 2.27% in 2018 and 0.66% in 2000, this according to the Centers for Disease Control and Prevention.



Kennedy has asserted that the U.S. is in the grip of an "autism epidemic" fueled by "environmental toxins



Trump teased another announcement coming next week, saying his administrator of the Centers for Medicare and Medicaid Services, Mehmet Oz, would roll out a "most favored nation" model for drug pricing.



This is meant to lower U.S. prescription drug prices to the lowest paid by countries that are members of the Organisation for Economic Co-operation and Development, which includes most of the world's largest economies.